TP53 and sarcoma: For example, the p53 synthetic lethal effects of an inhibitor of Wee1 G2 checkpoint kinase (AZD1775) are observed mainly in epithelial cancer cells, and it can inhibit tumor growth of sarcoma cells irrespective of the p53 status [117,159].